| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | VNM47R2QSQ |
| InChI Key | TZJALUIVHRYQQB-XLRXWWTNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C33H40O15 |
| Molecular Weight | 676.67 |
| AlogP | 0.07 |
| Hydrogen Bond Acceptor | 15.0 |
| Hydrogen Bond Donor | 8.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 238.2 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 48.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Phosphodiesterase
Phosphodiesterase 5
Phosphodiesterase 5A
|
- | 5900 | - | - | - | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 6
Phosphodiesterase 6C
|
- | - | - | - | 45 | |
|
Epigenetic regulator
Eraser
Lysine demethylase
Lysine-specific demethylase
|
- | 26440 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 127 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Bipolar Disorder; Disease; Substance-Related Disorders | Phase 3 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 489-32-7 |
| ChEBI | 78420 |
| ChEMBL | CHEMBL553204 |
| DrugBank | DB12052 |
| FDA SRS | VNM47R2QSQ |
| KEGG | C17555 |
| PubChem | 5318997 |
| SureChEMBL | SCHEMBL312615 |
| ZINC | ZINC000003960893 |